Author

Miriam Freimer

Observed names: Freimer Miriam, Freimer, Miriam

Institution: The Ohio State University Wexner Medical Center

Observed institutions: The Ohio State University Wexner Medical Center, The Ohio State University

OpenAlex ID: A5138319068

Corticosteroid dose tapering in patients with generalised myasthenia gravis on zilucoplan: interim analysis of RAISE-XT

2024 · Hewamadduma Channa, Genge Angela, et al. · 1

Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study

2026 · Shieh, Perry B., Freimer, Miriam, et al. · UNC Libraries

Zilucoplan-Associated Morpheaform Skin Changes and Methotrexate and UVA1 Phototherapy

2026 · Michelle M. Huynh, Miriam Freimer, et al. · JAMA Dermatology

Changes in corticosteroid and non-steroidal immunosuppressive therapy with long-term zilucoplan treatment in generalized myasthenia gravis

2026 · Leite, M. Isabel, Freimer, Miriam, et al. · UNC Libraries

Sustained Minimal Symptom Expression in Generalized Myasthenia Gravis: A 120-week Post Hoc Analysis of RAISE-XT (P9-9.001)

2026 · James F. Howard, Saskia Bresch, et al. · Neurology

Treatment Goals in Myasthenia Gravis: Expert Consensus Recommendations Using the RAND/UCLA Appropriateness Method (P4-9.004)

2026 · Pushpa Narayanaswami, Renato Mantegazza, et al. · Neurology

Phase II/III Study of Ulviprubart in Inclusion Body Myositis: Study Design, Patient Characteristics, and Topline Results (S7.007)

2026 · Namita A. Goyal, Pedro M. Machado, et al. · Neurology

Phase 2/3 study of an investigational anti-inflammatory biologic therapy in inclusion body myositis

2026 · Goyal, Namita, Machado, Pedro, et al. · Ghent University Academic Bibliography (Ghent University)

Works count: 9

Citation count: 1

H-index: 1

I10-index: